“There are no definitive recommendations [for which patients should receive an early transplant]. This depends on side effects they are having with the treatment, patient preference, age, etc. It is a decision that the physician and patient need to make depending on the goals,” Dr. Shaji Kumar of the Mayo Clinic in Rochester, Minnesota, told The Beacon. Dr. Kumar is the lead author of the current study.
Myeloma Beacon, Howard Chang, 11/1/11